Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
G1 Therapeutics Inc (GTHX)
NASDAQ:GTHX
G1 Therapeutics (GTHX) Stock Price & Analysis
1,730 Followers
GTHX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.08 - $11.78
Previous Close$1.23
Volume692.78K
Average Volume (3M)777.36K
Market Cap
$63.65M
Enterprise Value$15.28M
Total Cash (Recent Filing)$104.29M
Total Debt (Recent Filing)$55.93M
Price to Earnings (P/E)-0.7
Beta1.72
Next Earnings
Nov 08, 2023EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.71
Shares Outstanding51,745,578
10 Day Avg. Volume489,408
30 Day Avg. Volume777,364
Standard Deviation0.28
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.03
Price to Sales (P/S)1.47
Price to Cash Flow (P/CF)1.10
P/FCF Ratio1.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.17
Enterprise Value/Gross Profit0.30
Enterprise Value/Ebitda-0.39
Forecast
1Y Price Target
$11.00Price Target Upside794.31% Upside
Rating ConsensusHold
Number of Analyst Covering2
G1 Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GTHX FAQ
What was G1 Therapeutics Inc’s price range in the past 12 months?
G1 Therapeutics Inc lowest stock price was $1.08 and its highest was $11.78 in the past 12 months.
What is G1 Therapeutics Inc’s market cap?
Currently, no data Available
When is G1 Therapeutics Inc’s upcoming earnings report date?
G1 Therapeutics Inc’s upcoming earnings report date is Nov 08, 2023 which is in 21 days.
How were G1 Therapeutics Inc’s earnings last quarter?
G1 Therapeutics Inc released its earnings results on Aug 02, 2023. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of -$0.218 by $0.358.
Is G1 Therapeutics Inc overvalued?
According to Wall Street analysts G1 Therapeutics Inc’s price is currently Undervalued.
Does G1 Therapeutics Inc pay dividends?
G1 Therapeutics Inc does not currently pay dividends.
What is G1 Therapeutics Inc’s EPS estimate?
G1 Therapeutics Inc’s EPS estimate is -$0.34.
How many shares outstanding does G1 Therapeutics Inc have?
G1 Therapeutics Inc has 51,745,580 shares outstanding.
What happened to G1 Therapeutics Inc’s price movement after its last earnings report?
G1 Therapeutics Inc reported an EPS of $0.14 in its last earnings report, beating expectations of -$0.218. Following the earnings report the stock price went down -2.283%.
Which hedge fund is a major shareholder of G1 Therapeutics Inc?
Among the largest hedge funds holding G1 Therapeutics Inc’s share is Fisher Asset Management LLC. It holds G1 Therapeutics Inc’s shares valued at 6M.
---
G1 Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.00 (794.31% Upside)
$11.00 (794.31% Upside)
Blogger Sentiment
Bullish
GTHX Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 276.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 7.9%
Last 30 Days ▼ 7.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.29%
12-Months-Change
Fundamentals
Return on Equity
-125.62%
Trailing 12-Months
Asset Growth
-20.86%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
G1 Therapeutics Inc
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
---
Top 5 ETFs holding GTHX
Vanguard Total Stock Market ETF
$1.87M
Up to five ETFs with an Outperform Smart Score that hold GTHX. The ETFs are listed according to market value of GTHX within the ETF
Voyager Therapeutics
―
Gritstone Oncology
―
Cidara Therapeutics
―
Mirati Therapeutics
―
---